BOUSEIDA, Said,SANDOVAL MORALES, Federico,SARO SUAREZ, Jose Maria
申请号：
AU2018382966
公开号：
AU2018382966A1
申请日:
2018.12.13
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention relates to the treatment of cancer, in particular to the treatment of cancer using a CEA CD3 bispecific antibody and a PD-1 axis binding antagonist.
